List view / Grid view
21 October 2014 | By Amgen
Amgen announced the appointment of R. Sanders Williams, M.D., president of Gladstone Institutes and Gladstone's Robert W. and Linda L. Mahley Distinguished Professor...
21 October 2014 | By The European Medicines Agency
EMA encourages companies to apply for orphan designation...
20 October 2014 | By Doctors of the World UK
A new report by the think-tank Demos, supported by Doctors of the World, argues that encouraging earlier detection of health conditions amongst migrant communities would reduce NHS spending on treatment and reduce the wider public health risk by catching transmittable diseases early...
20 October 2014 | By SBRI Healthcare
Funding will accelerate development and NHS adoption of new technologies...
20 October 2014 | By Masters Speciality Pharma
Masters Speciality Pharma celebrates the anniversary of its foundation by Dr Zulf Masters, OBE, 30 years ago...
20 October 2014 | By Janssen
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor.
20 October 2014 | By Abbott
Abbott was named one of the Top 20 Employers by the journal Science...
20 October 2014 | By Nasdaq
Nasdaq announced that trading of Forward Pharma A/S (Nasdaq: FWP) commenced on The Nasdaq Stock Market on October 15, 2014....
20 October 2014 | By AstraZeneca
AstraZeneca, together with its global biologics research and development arm, MedImmune, announced that it has entered into four new collaborations with the University of Cambridge, building further on their existing partnership...
16 October 2014 | By METTLER TOLEDO
The extended and improved XS balance line incorporates patented weighing technologies to ensure accurate results whilst ergonomic design features provide outstanding comfort to protect user health during daily weighing tasks.
16 October 2014 | By METTLER TOLEDO
The new line of XPE balances focuses on delivering accurate, compliant results and provides users with a high level of process security, suitable for even the strictest regulations...
16 October 2014 | By Santen Pharmaceutical Co
Santen Pharmaceutical Co., Ltd. announced its new wholly owned subsidiary in Italy...
16 October 2014 | By Roche
Roche announce Q3 2014 results...
16 October 2014 | By GlobalData
In the battle against Ebola, incentives from governments and healthcare policymakers have been and will continue to be vital for advancing the current treatment pipeline, by mitigating the risk and up-front costs from pharmaceutical companies, says an analyst with research and consulting firm GlobalData...
16 October 2014 | By Roche
Roche announced that the U.S. Food and Drug Administration has approved Esbriet (pirfenidone) as a treatment for idiopathic pulmonary fibrosis in the United States...
